|
Lilly/Incyte pill beats placebo in mid-stage eczema trial
WHTC The Phase 2 eczema trial found that after 16 weeks, 61 percent of patients on the highest dose of baricitinib and a topical corticosteroid had at least a 50 percent reduction in symptoms, compared to 37 percent of patients treated with just a steroid … |
Tag Archives: midstage
Lilly/Incyte pill beats placebo in mid-stage eczema trial – WHTC
Reuters |
Lilly/Incyte pill beats placebo in mid-stage eczema trial
WHTC The Phase 2 eczema trial found that after 16 weeks, 61 percent of patients on the highest dose of baricitinib and a topical corticosteroid had at least a 50 percent reduction in symptoms, compared to 37 percent of patients treated with just a steroid … Baricitinib improves outcomes in patients with atopic dermatitis Lilly's baricitinib fails to outshine Sanofi's Dupixent Lilly Announces New Safety And Efficacy Data From Phase 2 Study Of Baricitinib |